Skip to content
Back to recalls
Drug FDA Class II Ongoing Contamination / non-sterility

Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution 0.2%/0.5%*, 5 mL, Rx Only, Sterile, Apotex Corp. Manufactured for: Apotex Corp., Weston, FL 33326, NDC 60505-0589-1.

Apotex Corp. Published Mar 25, 2026

Risk level

Class II

May cause a temporary or reversible health problem; slight chance of serious harm.

Severity score 60/100

What should you do?

  • Check whether you have this product, using the lot codes, UPCs, and dates listed below.
  • Do not eat, serve, or sell the affected product.
  • Return it to the place of purchase for a refund, or throw it away in a sealed bag so people and animals can’t get to it.
  • Contact Apotex Corp. or your place of purchase with questions, and see the source record below for full details.
Reason for recall

Lack of Assurance of Sterility

Hazards

Lack of Sterility Assurance · primary

Affected products (1)

Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution 0.2%/0.5%*, 5 mL, Rx Only, Sterile, Apotex Corp. Manufactured for: Apotex Corp., Weston, FL 33326, NDC 60505-0589-1.

BRIMONIDINE TARTRATE/TIMOLOL MALEATE OPHTHALMIC SOLUTION · 107,136 vials

NDC: 60505-0589, 60505-0589-1, 60505-0589-2, 60505-0589-3
Lot codes: VJ8599
Code info: Lots VJ8599, Exp Date 09/30/2026 & VL1668, Exp Date 01/31/2027

Affected areas

Nationwide

Timeline

  1. Initiated
    Mar 5, 2026
  2. Published
    Mar 25, 2026
Recall number
D-0407-2026
Agency
U.S. Food and Drug Administration
Country
US
Source data (openFDA JSON) About FDA enforcement reports

FDA records come from the openFDA drug enforcement-report dataset — the agency's full weekly enforcement list. Most entries are not issued as consumer press releases, so they won't appear on fda.gov/recalls or in a web search. The source record link above resolves this exact recall by its number.